Physician profile
Mark M Ruff
NPI 1831120096
$1,536.61
in general payments reported to CMS, 2019-2025
16 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $103 · 2021: $111 · 2022: $205 · 2023: $214 · 2024: $162 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767 · Entertainment: $38.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.34 |
| Entertainment | $38.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $327.39 | 2019-2025 | Myday Contact Lens |
| Genmab U.S., INC. | $239.58 | 2023-2025 | Tivdak |
| Maculogix, INC. | $150.00 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $137.79 | 2019 | |
| Lkc Technologies, INC. | $120.48 | 2024-2025 | |
| Lombart Brothers, INC. | $99.34 | 2019-2024 | Opd-III |
| Dompe US, INC. | $96.15 | 2025 | Oxervate |
| Optos, INC. | $82.36 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $66.56 | 2022 | |
| Optovue, INC. | $58.00 | 2020 | |
| Biotissue Holdings INC. | $47.08 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $39.13 | 2023 | Infuse |
| Tarsus Pharmaceuticals, INC. | $31.89 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $16.21 | 2022 | |
| Abbvie INC. | $13.45 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ruff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.